BENFOTHIAMINE ADMINISTRATION IN PATIENTS WITH DILATED CARDIOMYOPATHY AND ADVANCED HEART FAILURE WITH CHRONIC DIURETIC TREATMENT
Date
2017-03-30
Authors
Dana-Adriana ILUȚIU-VARVARA
Dan RĂDULESCU
Valer Ioan DONCA
Journal Title
Journal ISSN
Volume Title
Publisher
STUDIA UBB CHEMIA. Published by Babeş-Bolyai University
Abstract
It is well known that long term administration of high dose loop diuretics in patients with heart failure, may in some cases aggravate the cardiac failure symptoms. Part of this effect may be due to thiamine depletion secondary to diuretics use. The aim of our present study was to assess whether administration of benfothiamine in patients with advanced congestive cardiac failure treated on long term with high dose loop diuretics, can prevent the alteration of heart failure.
Description
STUDIA UBB CHEMIA, LXII, 1, 2017 (p. 229-236), DOI:10.24193/subbchem.2017.1.20
Dana-Adriana ILUȚIU-VARVARA
Facultatea de Instalaţii, Universitatea Tehnică, Cluj-Napoca, Romania, dana.adriana.varvara@insta.utcluj.ro
https://orcid.org/0000-0003-1141-5570
Dan RĂDULESCU
Universitatea de Medicină şi Farmacie Iuliu Hațieganu, Facultatea de Medicină, Cluj-Napoca, Romania
*Corresponding author: dan_rad31@yahoo.com
Valer Ioan DONCA
Universitatea de Medicină şi Farmacie Iuliu Hațieganu, Facultatea de Medicină, Cluj-Napoca, Romania, ioan.donca@umfcluj.ro
https://orcid.org/0000-0003-0231-2131
Keywords
benfothiamine, cardiovascular diseases, cardiomyopathy, diuretic treatment, heart failure, thiamine
Citation
D. Loew, International Journal of Clinical Pharmacology and Therapeutics, 1996, 34, 47.
Howard Smithline, M. Donnino, D.J. Greenblatt, BMC Clinical Pharmacology, 2012, 12, 4.
K.T. Weber, Journal of the American College of Cardiology, 2004, 44, 1308.
J. Lu, E.L. Frank, Clinical Chemistry, 2008, 54, 901.
D. Leslie, M. Gheorghiade, American Heart Journal, 1996, 131, 1.
Shimon, S. Almog, Z. Vered, H. Seligmann, M. Shefi, E. Peleg, American Journal of Medicine, 1995, 98, 485.
M. Fujiwara, H. Watanabe, K. Matsui, Journal of Biochemistry, 1954, 41, 29.
P. Balakumar, A. Rohilla, P. Krishan, P. Solairaj, A. Thangathirupathi, Pharmacological Research, 2010, 61, 482.
M.L. Volvert, S. Seyen, M. Piette, B. Evrard, M. Gangolf, J.C. Plumier, L. Bettendorff, BMC Clinical Pharmacology, 2008, 8, 10.
Stirban, M. Negrean, B. Stratmann, Diabetes Care, 2006, 29, 2064.
Stirban, M. Negrean, B. Stratmann, Diabetes Care, 2007, 30, 10.
D.A. Fraser, N.P. Hessvik, N. Nikolić, V. Aas, K.F. Hanssen, S.K. Bøhn, G.H. Thoresen, A.C. Rustan, Genes & Nutrition, 2012, 7, 459.
Greb, R. Bitsch, International Journal of Clinical Pharmacology and Therapeutics, 1998, 36, 216.
D. Lonsdale, Evidence Based Complementary and Alternative Medicine, 2006, 3, 49.
P. Vinas, M. Bravo-Bravo, I. Lopez-Garcia, M. Hernandez-Cordoba, Analytical Methods, 2012, 4, 2759.
R.G. Katare, A. Caporali, A. Oikawa, M. Meloni, C. Emanurli, P. Madeddu, Circulation Heart Failure, 2010, 3, 294.
J. DiNicolantonio, C.J. Lavie, A.K. Niazi, J.H. O’Keefe, T. Hu, Ochsner Journal, 2013, 13, 495.
R. Katare, A. Caporali, C Emanueli, P. Madeddu, Journal of Molecular and Cellular Cardiology, 2010, 49, 625.
H. Stracke, H.P. Hammes, D. Werkmann, K. Mavrakis, I. Bitsch, M. Netzel, Experimental and Clinical Endocrinology & Diabetes, 2001, 109, 330.
M.L. Volvert, S. Seven, M. Piette, B. Evrard, M. Gangolf, J.C. Plumier, BMC Pharmacology, 2008, 12, 8.
S. Hazell, S. Faim, G. Wertheimer, V. R. Silva, C. S. Marques, Neurochemistry International, 2013, 62, 796.
Stirban, M. Negrean, B. Stratmann, T. Gawlowski, T. Horstmann, C. Gotting, Diabetes Care, 2006, 29, 2064.
Nenna, F. Nappi, S.S. Avtaar Singh, F.W. Sutherland, F. Di Domenico, M. Chello, C. Spadaccio, Research in Cardiovascular Medicine, 2015, 23, 2.